Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer

Julia Tchou*, Paul J. Zhang, Yingtao Bi, Celine Satija, Rajrupa Marjumdar, Tom L. Stephen, Albert Lo, Haiying Chen, Carolyn Mies, Carl H. June, Jose Conejo-Garcia, Ellen Puré

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    41 Scopus citations


    Fibroblast activation protein (FAP) has long been known to be expressed in the stroma of breast cancer. However, very little is known if the magnitude of FAP expression within the stroma may have a prognostic value and reflect the heterogeneous biology of the tumor cell. An earlier study had suggested that stromal FAP expression in breast cancer was inversely proportional to prognosis. We, therefore, hypothesized that stromal FAP expression may correlate with clinicopathologic variables and may serve as an adjunct prognostic factor in breast cancer. We evaluated the expression of FAP in a panel of breast cancer tissues (n = 52) using a combination of immunostain analyses at the tissue and single-cell level using freshly frozen or freshly digested human breast tumor samples, respectively. Our results showed that FAP expression was abundantly expressed in the stroma across all breast cancer subtypes without significant correlation with clinicopathologic factors. We further identified a subset of FAP-positive (or FAP+) stromal cells that also expressed CD45, a pan-leukocyte marker. Using freshly dissociated human breast tumor specimens (n = 5), we demonstrated that some of these FAP+CD45+ cells were CD11b+CD14+MHC-II+, indicating that they were likely tumor-associated macrophages (TAMs). Although FAP +CD45+ cells have been demonstrated in the mouse tumor stroma, our results demonstrating that human breast TAMs expressed FAP were novel and suggested that existing and future FAP-directed therapy may have dual-therapeutic benefits targeting both stromal mesenchymal cells and immune cells such as TAMs. More work is needed to explore the role of FAP as a potential targetable molecule in breast cancer treatment.

    Original languageEnglish (US)
    Pages (from-to)2549-2557
    Number of pages9
    JournalHuman pathology
    Issue number11
    StatePublished - Nov 2013


    • FAP expression
    • Human breast cancer
    • Tumor-associated macrophages

    ASJC Scopus subject areas

    • Pathology and Forensic Medicine

    Fingerprint Dive into the research topics of 'Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer'. Together they form a unique fingerprint.

    Cite this